MP
Madrigal Pharmaceuticals Inc
🇺🇸XNAS.MDGLUnited StatesHealthcare
$522.43USDdown -1.53 (-0.29%)OpenDelayed3:24 PM
Price$522.43-1.53 (-0.29%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US5588681057
- CUSIP
- 87162T206
Company
- Employees
- 915
- Headquarters
- West Conshohocken, United States
- CEO
- Mr. William J. Sibold
Market
- Shares outstanding
- 23.1M
- Market cap
- $12.07B
Key dates
- Next earnings
- Nov 3, 2026
Highlights
- Market cap
- $12.05B
- EPS LTM
- -$14.07calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -37.13calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $1.28B+149.04%up year on year
- Net income
- -$325.1M-15.32%down year on year
- Gross margin
- 91.48%-4.99%down year on year
- Free cash flow
- -$206.29M+33.11%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.